Telix Pharmaceuticals | Attività Correnti



Current Assets Cambiamento Data
Cochlear AUD 1.41B 41.5M 2024-12
CSL USD 11.31B 540M 2024-12
Integral Diagnostics AUD 74.82M 9.15M 2024-06
Mayne Pharma AUD 460.59M 14.71M 2024-06
Medical Developments International AUD 33.41M 7.26M 2024-12
Mesoblast 86.46M 1.31M 2024-06
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Pacific Edge NZD 44.31M 13.57M 2024-09
Paradigm Biopharmaceuticals AUD 32.29M 8.04M 2024-12
Polynovo AUD 79.3M 9.02M 2024-06
PYC Therapeutics AUD 62.12M 23.49M 2024-12
Ramsay Health Care AUD 3.41B 465.3M 2024-12
ResMed USD 2.84B 195.05M 2024-12
Sonic Healthcare AUD 2.3B 52.76M 2024-12



Telix Pharmaceuticals Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jun 2025.